These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7580798)

  • 1. Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.
    Gilleland HE; Hughes EE; Gilleland LB; Matthews-Greer JM; Staczek J
    Curr Microbiol; 1995 Nov; 31(5):279-86. PubMed ID: 7580798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa.
    Hughes EE; Gilleland LB; Gilleland HE
    Infect Immun; 1992 Sep; 60(9):3497-503. PubMed ID: 1379985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ability of synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa to afford protection against P. aeruginosa infection in a murine acute pneumonia model.
    Hughes EE; Gilleland HE
    Vaccine; 1995 Dec; 13(18):1750-3. PubMed ID: 8701588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptides representing two protective, linear B-cell epitopes of outer membrane protein F of Pseudomonas aeruginosa elicit whole-cell-reactive antibodies that are functionally pseudomonad specific.
    Gilleland LB; Gilleland HE
    Infect Immun; 1995 Jun; 63(6):2347-51. PubMed ID: 7539410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
    Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
    Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa.
    Staczek J; Bendahmane M; Gilleland LB; Beachy RN; Gilleland HE
    Vaccine; 2000 Apr; 18(21):2266-74. PubMed ID: 10717347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; Garcia-Sastre A; Engelhardt OG; Palese P
    Behring Inst Mitt; 1997 Feb; (98):291-301. PubMed ID: 9382753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis by flow cytometry of surface-exposed epitopes of outer membrane protein F of Pseudomonas aeruginosa.
    Hughes EE; Matthews-Greer JM; Gilleland HE
    Can J Microbiol; 1996 Aug; 42(8):859-62. PubMed ID: 8776855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.
    Staczek J; Gilleland HE; Gilleland LB; Harty RN; García-Sastre A; Engelhardt OG; Palese P
    Infect Immun; 1998 Aug; 66(8):3990-4. PubMed ID: 9673294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model.
    Matthews-Greer JM; Gilleland HE
    J Infect Dis; 1987 Jun; 155(6):1282-91. PubMed ID: 3033095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.
    Su H; Morrison RP; Watkins NG; Caldwell HD
    J Exp Med; 1990 Jul; 172(1):203-12. PubMed ID: 1694217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of overlapping synthetic peptides covering the entire sequence of Haemophilus influenzae type b outer membrane protein P2.
    Chong P; Yang YP; Fahim R; McVerry P; Sia C; Klein M
    Infect Immun; 1993 Jun; 61(6):2653-61. PubMed ID: 8500904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of alginate to a synthetic peptide containing T- and B-cell epitopes as an induction for protective immunity against Pseudomonas aeruginosa.
    Farjaha A; Owlia P; Siadat SD; Mousavi SF; Shafieeardestani M
    J Biotechnol; 2014 Dec; 192 Pt A():240-7. PubMed ID: 25449544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of ScFv antibody fragments following immunization with a phage-displayed fusion protein and analysis of reactivity to surface-exposed epitopes of the protein F of Pseudomonas aeruginosa by cytofluorometry.
    Kermani P; Péloquin L; Lagacé J
    Hybridoma; 1995 Aug; 14(4):323-8. PubMed ID: 8522342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of the protective efficacy of an oprF DNA vaccine against Pseudomonas aeruginosa.
    Price BM; Barten Legutki J; Galloway DR; von Specht BU; Gilleland LB; Gilleland HE; Staczek J
    FEMS Immunol Med Microbiol; 2002 Jun; 33(2):89-99. PubMed ID: 12052563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1.
    Chong P; Yang YP; Persaud D; Haer M; Tripet B; Tam E; Sia C; Klein M
    Infect Immun; 1995 Oct; 63(10):3751-8. PubMed ID: 7558276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.